Global Specialty Enzymes Industry

Aug 06, 2015, 17:51 ET from ReportBuyer

LONDON, Aug. 6, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following Product Segments: Proteases, Polymerases, Carbohydrases, and Other Specialty Enzymes. The report is also analyzed by the following End-Use Applications: Pharmaceutical & Diagnostics, Research/ Biotechnology, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 41 companies including many key and niche players such as -

Advanced Enzymes Technologies Limited
Affymetrix, Inc.
Amano Enzyme, Inc.
Biocatalysts Ltd.
BBI Solutions

Download the full report: https://www.reportbuyer.com/product/90599/

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Product Segments I-4
Proteases I-4
Polymerases I-4
Carbohydrases I-4
Other Specialty Enzymes I-4
End-Use Segments I-4
Pharmaceutical & Diagnostics I-4
Research/Biotechnology I-4
Other End-Uses I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Specialty Enzymes: Indispensable to the Pharmaceutical Industry II-1
Table 1: Global Market for Pharmaceutical/Diagnostics Enzymes
by Application (2015E): Percentage Breakdown for Diagnostics,
Digestive, Enzyme Replacement Therapy, Thrombolytic, and
Others (includes corresponding Graph/Chart) II-2
Outlook II-2
Developed Regions Dominate Global Demand II-4
Table 2: Global Market for Specialty Enzymes by Geographic
Region/Country (2015E): Percentage Breakdown of Value Sales
for Asia-Pacific, Canada, Europe, Japan, Latin America, the
US, and Rest of World (includes corresponding Graph/Chart) II-4

Table 3: Healthcare Spending as a Percentage of GDP by
Geographic Region - North America, Western Europe, Latin
America, Eastern Europe, Asia, and Middle East & Africa:
2015E (includes corresponding Graph/Chart) II-5

Table 4: Per-Capita Healthcare Expenditure in Select Regions -
The US, EU, Asia, and China: 2014E (includes corresponding
Graph/Chart) II-5

2. MARKET TRENDS, ISSUES AND DRIVERS II-6
Robust Demand from the Pharmaceutical Industry: A Strong
Growth Driver II-6
Table 5: Global Market for Pharmaceuticals by Medication
Class (2014): Percentage Breakdown of Value Sales for
Anti-Infectives, Biologicals, Cardiovascular Drugs, Central
Nervous System Drugs, Dermatological Agents, Gastrointestinal
Agents, Hormones and Metabolic Agents, Nutritional
Preparations, Ophthalmic Agents, Respiration Medications, and
Other Medications (includes corresponding Graph/Chart) II-7
Pharmaceutical Medication Class and Respective Growth Drivers II-8
Some Important Specialty Enzymes and their Therapeutic Uses II-9
Nattokinase Lowers Risk of Blood Clots II-9
Seaprose-S: Effective in Break-up of Mucus II-10
Papain and Bromelain: Anti-Inflammatory Agents II-10
Serratiopeptidase: Anti-Inflammation and Analgesic Agent II-10
Some Important Therapeutic Enzymes and their Source II-10
Sources of Therapeutic Enzymes by Type: Listing of Source
and Enzyme Derived for Animal Sources, Plant Sources, and
Microbial Sources II-11
Specialty Enzymes Reduce Pharmaceutical Production Costs II-11
Rising Prominence in Disease Diagnosis Expands Market
Opportunities II-12
Focus on Preventive Medicine Spurs Growth in the Diagnostic
Enzymes Market II-12
Expanding Home Glucose Testing Market Bodes Well for Enzymes
in Diagnostic Applications II-13
Increasing Diabetes Incidence Worldwide: Key Opportunity
Indicator II-14
Table 6: Global Diabetes Mellitus Incidence among Ages
20-79 (2014E & 2035P): Prevalence (in Millions) and
Percentage Share by Geographic Region (includes
corresponding Graph/Chart) II-14
Specialty Enzyme Advancements: Spearheading Growth II-14
University of Pittsburgh Discovers the First Halogenations
Enzyme II-15
Growing Significance of Systemic Enzymes in Human Health
Strengthens Market Prospects II-15
Systemic Enzymes Aids in Effective Pain and Inflammation
Management II-16
Serrapeptase Enzyme: An Anti-Edemic and Anti-Inflammatory Agent II-17
EXCLZYME: An Apt Replacement for NSAIDS? II-17
Systemic Enzyme Therapy Relieve Painful Effects of Cancer
Therapies II-18
Systemic Enzymes for Nutritional Support throughout the Body II-18
Regenerative Medicine: A Niche Market Beckons II-19
Increasing Consumption in Health Supplements Augurs Well for
the Market II-19
Rising Adoption of Enzyme Supplements Spurs Product Innovation II-20
Spiraling Healthcare Costs: An Important Opportunity
Indicator for Supplemental Enzymes II-20
Role of Specialty Enzymes in Supporting Cardiovascular Health
Boosts Market Prospects II-21
Cardiovascular Disease (CVD) Facts and Figures II-21
Key CVD Statistics II-22
Table 7: Global Annual Medical Cost of CVD in US$ Billion
(2010-2030) (includes corresponding Graph/Chart) II-22

Table 8: Fatalities by Heart Conditions - Estimated
Percentage Breakdown for Cardiovascular Disease, Ischemic
Heart Disease, Stroke, and Others (includes corresponding
Graph/Chart) II-22
Specialty Enzymes in Alzheimer's, Parkinson's, and Cancer
Therapies Benefit Market Expansion II-23
Cancer Cases: Important Opportunity Indicator II-23
Table 9: Worldwide Incidence of Cancer (2013, 2020 & 2030):
Number of New Cases Diagnosed (includes corresponding
Graph/Chart) II-23

Table 10: World Cancer Incidence by Geographic Region and
Gender (2012): Number of New Cancer Cases Reported in
Thousands for Asia-Oceania, Europe, North America, Latin
America & the Caribbean, and Africa (includes corresponding
Graph/Chart) II-24
Enzyme Replacement Therapies for Lysosomal Storage Diseases (
LSDs) Holds Promise II-24
Aging Population Spurs Demand for Pharmaceutical and
Diagnostic Enzymes II-25
Table 11: Global Population Statistics for the 65+ Age Group
(2013) (includes corresponding Graph/Chart) II-26

Table 12: Global Aging Population by Age Group: 1975-2050
(includes corresponding Graph/Chart) II-27
Specialty Enzyme as Biocatalysts in the Manufacture of Drugs
and Fine Chemicals II-27
Focus on Green Manufacturing Processes Drive Demand for
Biocatalysts II-28
Advancements in Enzyme Manufacturing Processes Aids Growth II-29
Immobilization of Enzymes Opens up a World of Opportunities II-29
European Food Enzymes Industry Shifts Focus towards Specialty
Enzymes from Commodity Enzymes II-30
Strong Research Activity Bodes Well for Research and
Biotechnology Enzymes II-31
Surging Demand for Eco-Friendly Enzymes Spurs R&D II-31
Developing Countries: Potential Laden Markets II-32
Table 13: Global Specialty Enzymes Market - Geographic
Regions Ranked by CAGR for 2014-2020: Asia-Pacific, Latin
America, the US, Canada, Europe, Japan, and Rest of World
(includes corresponding Graph/Chart) II-32
Manufacturers in Developed Countries Move Production Base to
Developing Markets II-33
Alkaline Phosphatase (ALP): A Key Diagnostic & Research Enzyme II-33
Diagnostics II-33
As a Diagnostic Enzyme in the Dairy Industry II-34
Research II-34
Regulatory Issues to Ensure Safety of Enzyme Usage II-35
CRN & ETA Issue Guideline for Enzyme Supplements II-35

3. PRODUCT OVERVIEW II-36
Enzymes: An Introduction II-36
A Brief History II-36
Categorization of Enzymes II-37
Advantages of Enzymes over Chemical Catalysts II-37
Classification of Enzymes Based on Application II-38
Industrial Enzymes II-38
Specialty Enzymes II-38
Proteases II-38
Polymerases II-39
Carbohydrases II-39
Other Specialty Enzymes II-40
Nucleases II-40
Lipases II-40
Catalases II-41
Oxidase II-41
Laccases II-41
Phytases II-41

4. PRODUCT INTRODUCTIONS/INNOVATIONS II-42
GingisKHAN, a New Enzyme Product, Launched by Genovis AB II-42
BioMarin Secures FDA Approval for VimiZim™ II-42
Specialty Enzymes Unveils FlavorSEB L Enzyme Series for Pet
Food Processing II-42
Enzymedica Unveils Digest Gold with ATProacents II-42
Deerland Enzymes Unveils New Enzyme-based Technologies II-42
Sekisui Enzymes Introduces New Thermostable Enzyme Range II-42
Codexis Launches Improved CodeXyme® II-43
Deerland Enzymes Introduces New ThioZymeYD Dietary Supplement II-43
Sekisui Enzymes Introduces New ß-Lactamase Enzyme II-43

5. RECENT INDUSTRY ACTIVITY II-44
Novozymes and China National Pharmaceutical Foreign Trade
Enter Distribution Deal II-44
GSK & Codexis Enter Technology Licensing Agreement II-44
Connell Brothers Takes Over Enzyme Solutions II-44
Codexis Enters Product Development Deal with Purolite II-44
Sekisui Diagnostics Announces New Headquarters in Massachusetts II-44
Specialty Enzymes Expands Enzyme Products Manufacturing Capacity II-44
Cornerstone Therapeutics Inks Agreement with Digestive Care II-45
Codexis Extends Process and Catalyst Development Agreement
with Merck II-45
GENETRIX Inks Licensing Agreement with QIAGEN II-45
Anil Bioplus to Establish Production Unit at Halol II-45

6. FOCUS ON SELECT GLOBAL PLAYERS II-46
Advanced Enzymes Technologies Limited (India) II-46
Advanced Vital Enzymes Ltd. (India) II-46
AST Enzymes (US) II-47
Specialty Enzymes & Biotechnologies Co. (US) II-47
Affymetrix, Inc. (US) II-47
Amano Enzyme, Inc. (Japan) II-48
Biocatalysts Ltd. (UK) II-48
BBI Solutions (UK) II-48
Chr. Hansen A/S (Denmark) II-49
Codexis, Inc. (US) II-49
F. Hoffmann-La Roche Ltd. (Switzerland) II-49
Genzyme Corporation (US) II-50
Life Technologies (US) II-50
Meteoric Life Sciences (India) II-51
Nagase & Co. Ltd (Japan) II-51
National Enzyme Company (US) II-51
The Soufflet Group (France) II-52

7. GLOBAL MARKET PERSPECTIVE II-53
Table 14: World Recent Past, Current & Future Analysis for
Specialty Enzymes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-53

Table 15: World Historic Review for Specialty Enzymes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) II-54

Table 16: World 14-Year Perspective for Specialty Enzymes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) II-55
Specialty Enzymes Market by Product Segment II-56
Table 17: World Recent Past, Current & Future Analysis for
Proteases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-56

Table 18: World Historic Review for Proteases by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding Graph/Chart) II-57

Table 19: World 14-Year Perspective for Proteases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) II-58

Table 20: World Recent Past, Current & Future Analysis for
Polymerases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-59

Table 21: World Historic Review for Polymerases by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding Graph/Chart) II-60

Table 22: World 14-Year Perspective for Polymerases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) II-61

Table 23: World Recent Past, Current & Future Analysis for
Carbohydrases by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-62

Table 24: World Historic Review for Carbohydrases by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) II-63

Table 25: World 14-Year Perspective for Carbohydrases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) II-64

Table 26: World Recent Past, Current & Future Analysis for
Other Enzymes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2014 through 2020 (includes
corresponding Graph/Chart) II-65

Table 27: World Historic Review for Other Enzymes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2013 (includes corresponding
Graph/Chart) II-66

Table 28: World 14-Year Perspective for Other Enzymes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) II-67
Specialty Enzymes Market by End-Use Segment II-68
Table 29: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) II-68

Table 30: World Historic Review for Specialty Enzymes
Consumption in Pharmaceuticals & Diagnostics by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2013 (includes corresponding Graph/Chart) II-69

Table 31: World 14-Year Perspective for Specialty Enzymes
Consumption in Pharmaceuticals & Diagnostics by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets for Years 2007, 2015 & 2020
(includes corresponding Graph/Chart) II-70

Table 32: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Research/Biotechnology by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) II-71

Table 33: World Historic Review for Specialty Enzymes
Consumption in Research/ Biotechnology by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2013 (includes corresponding Graph/Chart) II-72

Table 34: World 14-Year Perspective for Specialty Enzymes
Consumption in Research/ Biotechnology by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) II-73

Table 35: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Other End-Use Segments by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2014 through 2020 (includes corresponding
Graph/Chart) II-74

Table 36: World Historic Review for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2013 (includes corresponding Graph/Chart) II-75

Table 37: World 14-Year Perspective for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) II-76


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Specialty Enzymes Market Overview III-1
Specialty and Industrial Enzymes: Gradual Narrowing of
Differences III-2
Discovery of the First Halogenations Enzyme: Market
Implications III-2
Enzymes for Food Analysis and Testing: Key Challenges Faced III-2
Aging Population Spurs Demand for Therapeutic and Diagnostic
Enzymes III-3
Table 38: North American Aging Population by Age Group:
1975-2050 (includes corresponding Graph/Chart) III-3
CRN & ETA Issue Guideline for Enzyme Supplements III-4
Product Launches III-4
Recent Industry Activity III-5
Key Players III-6
B.Market Analytics III-9
Table 39: US Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-9

Table 40: US Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-10

Table 41: US 14-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-11

Table 42: US Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-12

Table 43: US Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-13

Table 44: US 14-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/Biotechnology, and
Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-14

2. CANADA III-15
A.Market Analysis III-15
Current and Future Analysis III-15
B.Market Analytics III-16
Table 45: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-16

Table 46: Canadian Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-17

Table 47: Canadian 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-18

Table 48: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-19

Table 49: Canadian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-20

Table 50: Canadian 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-21

3. JAPAN III-22
A.Market Analysis III-22
Current and Future Analysis III-22
Expanding Aging Population Offers Opportunities for
Pharmaceutical Enzymes III-22
Table 51: Japanese Elderly (65+ Years) Population:
2000-2020 (includes corresponding Graph/Chart) III-22
Key Players III-23
B.Market Analytics III-24
Table 52: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-24

Table 53: Japanese Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-25

Table 54: Japanese 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-26

Table 55: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-27

Table 56: Japanese Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-28

Table 57: Japanese 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-29

4. EUROPE III-30
A.Market Analysis III-30
Current and Future Analysis III-30
Accelerating Trend towards Environmentally Friendly Enzymes III-30
Enzymes for Research and Biotechnology to Report Faster Gains III-30
European Food Enzymes Industry Shifts Focus towards
Specialty Enzymes from Commodity Enzymes III-31
Aging Population Boosts Demand for Pharmaceutical and
Diagnostic Enzymes III-31
Table 58: European Aging Population by Age Group: 1975-2050
(includes corresponding Graph/Chart) III-32

Table 59: European Country-wise Statistics of 60+
Population as % of Total Population: 2013 (includes
corresponding Graph/Chart) III-33
B.Market Analytics III-34
Table 60: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Geographic Region - France,
Germany, Italy, UK, Spain, Russia, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-34

Table 61: European Historic Review for Specialty Enzymes by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Thousands for Years 2007
through 2013 (includes corresponding Graph/Chart) III-35

Table 62: European 14-Year Perspective for Specialty Enzymes
by Geographic Region - Percentage Breakdown of Dollar Sales
for France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-36

Table 63: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-37

Table 64: European Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-38

Table 65: European 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-39

Table 66: European Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-40

Table 67: European Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-41

Table 68: European 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-42

4a. FRANCE III-43
A.Market Analysis III-43
Current and Future Analysis III-43
The Soufflet Group - A Key Regional Player III-43
B.Market Analytics III-44
Table 69: French Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-44

Table 70: French Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-45

Table 71: French 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-46

Table 72: French Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-47

Table 73: French Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-48

Table 74: French 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-49

4b. GERMANY III-50
A.Market Analysis III-50
Current and Future Analysis III-50
B.Market Analytics III-51
Table 75: German Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-51

Table 76: German Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-52

Table 77: German 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-53

Table 78: German Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-54

Table 79: German Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-55

Table 80: German 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-56

4c. ITALY III-57
A.Market Analysis III-57
Current and Future Analysis III-57
B.Market Analytics III-58
Table 81: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-58

Table 82: Italian Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-59

Table 83: Italian 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-60

Table 84: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-61

Table 85: Italian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-62

Table 86: Italian 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-63

4d. THE UNITED KINGDOM III-64
A.Market Analysis III-64
Current and Future Analysis III-64
Product Launches III-64
Key Players III-64
B.Market Analytics III-66
Table 87: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-66

Table 88: UK Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-67

Table 89: UK 14-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-68

Table 90: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-69

Table 91: UK Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-70

Table 92: UK 14-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/Biotechnology, and
Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-71

4e. SPAIN III-72
A.Market Analysis III-72
Current and Future Analysis III-72
Recent Industry Activity III-72
B.Market Analytics III-73
Table 93: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-73

Table 94: Spanish Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-74

Table 95: Spanish 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-75

Table 96: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-76

Table 97: Spanish Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-77

Table 98: Spanish 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-78

4f. RUSSIA III-79
A.Market Analysis III-79
Current and Future Analysis III-79
B.Market Analytics III-80
Table 99: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-80

Table 100: Russian Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-81

Table 101: Russian 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-82

Table 102: Russian Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/ Biotechnology, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-83

Table 103: Russian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-84

Table 104: Russian 14-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology,
and Others Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-85

4g. REST OF EUROPE III-86
A.Market Analysis III-86
Current and Future Analysis III-86
Product Launch III-86
Key Players III-86
B.Market Analytics III-88
Table 105: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-88

Table 106: Rest of Europe Historic Review for Specialty
Enzymes by Product Segment - Proteases, Polymerases,
Carbohydrases and Other Enzymes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-89

Table 107: Rest of Europe 14-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Proteases, Polymerases, Carbohydrases and Other
Enzymes Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-90

Table 108: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/Biotechnology, and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2014 through 2020
(includes corresponding Graph/Chart) III-91

Table 109: Rest of Europe Historic Review for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/ Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-92

Table 110: Rest of Europe 14-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology, and Others Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) III-93

5. ASIA-PACIFIC III-94
A.Market Analysis III-94
Current and Future Analysis III-94
Specialty Enzymes at Par with Industrial Enzymes in APAC III-94
Asian Countries: Strong Markets with Huge Untapped Potential III-94
Table 111: Global Market for Specialty Enzymes (2014-2020):
Ranked by CAGR for Asia-Pacific, Latin America, US, Canada,
Europe, Japan, and Rest of World (includes corresponding
Graph/Chart) III-95

Table 112: Asian Aging Population by Age Group: 1975-2050
(includes corresponding Graph/Chart) III-95
India & China: Potential Laden Markets for Pharma and
Diagnostic Enzymes III-96
Table 113: China and India Lead Global Population (July
2013): China and India's Huge Population Vis-a-vis Other
Countries' Population (in Million) by Age Group (includes
corresponding Graph/Chart) III-96
Manufacturers in Developed Countries Move Production Base to
Developing Markets III-97
B.Market Analytics III-98
Table 114: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by Geographic Region - China,
India, South Korea and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-98

Table 115: Asia-Pacific Historic Review for Specialty
Enzymes by Geographic Region - China, India, South Korea and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2007 through
2013 (includes corresponding Graph/Chart) III-99

Table 116: Asia-Pacific 14-Year Perspective for Specialty
Enzymes by Geographic Region - Percentage Breakdown of
Dollar Sales for China, India, South Korea and Rest of
Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-100

Table 117: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-101

Table 118: Asia-Pacific Historic Review for Specialty
Enzymes by Product Segment - Proteases, Polymerases,
Carbohydrases and Other Enzymes Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-102

Table 119: Asia-Pacific 14-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Proteases, Polymerases, Carbohydrases and Other
Enzymes Markets for Years 2007, 2015 & 2020 (includes
corresponding Graph/Chart) III-103

Table 120: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/Biotechnology, and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2014 through 2020
(includes corresponding Graph/Chart) III-104

Table 121: Asia-Pacific Historic Review for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/ Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2007 through 2013 (includes corresponding Graph/Chart) III-105

Table 122: Asia-Pacific 14-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology, and Others Markets for Years 2007, 2015 &
2020 (includes corresponding Graph/Chart) III-106

5a. CHINA III-107
A.Market Analysis III-107
Current and Future Analysis III-107
Chinese Enzyme Demand by End-Use III-107
Table 123: Chinese Enzyme Market by End-Use Sector (2014):
Percentage Breakdown of Value Sales for Industrial (Animal
Feed, Cleaning Products, Ethanol Production, Food &
Beverage, and Other Industrial) and Specialty (includes
corresponding Graph/Chart) III-107
Enzyme Demand by Enzyme Type III-108
Table 124: Chinese Enzyme Market by Type (2014): Percentage
Breakdown of Value Sales for Carbohydrases (Amylases and
Other Carbohydrases), Lipases, Polymerases & Nucleases,
Proteases, and Other Enzymes (includes corresponding
Graph/Chart) III-108
Strategic Corporate Development III-108
B.Market Analytics III-109
Table 125: Chinese Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Proteases,
Polymerases, Carbohydrases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2014 through 2020 (includes
corresponding Graph/Chart) III-109

Table 126: Chinese Historic Review for Specialty Enzymes by
Product Segment - Proteases, Polymerases, Carbohydrases and
Other Enzymes Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2007 through 2013
(includes corresponding Graph/Chart) III-110

Table 127: Chinese 14-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Proteases, Polymerases, Carbohydrases and Other Enzymes
Markets for Years 2007, 2015 & 2020 (includes corresponding
Graph/Chart) III-111

Table 128: Chinese Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnolo
Download the full report: https://www.reportbuyer.com/product/90599/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer



RELATED LINKS

http://www.reportbuyer.com